Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 49

1.

IFN-γ-dependent nitric oxide suppresses Brucella-induced arthritis by inhibition of inflammasome activation.

Lacey CA, Chambers CA, Mitchell WJ, Skyberg JA.

J Leukoc Biol. 2019 Jul;106(1):27-34. doi: 10.1002/JLB.4MIA1018-409R. Epub 2019 Feb 12.

PMID:
30748031
2.

Cutting edge: Dab2 is a FOXP3 target gene required for regulatory T cell function.

Jain N, Nguyen H, Friedline RH, Malhotra N, Brehm M, Koyanagi M, Bix M, Cooper JA, Chambers CA, Kang J.

J Immunol. 2009 Oct 1;183(7):4192-6. doi: 10.4049/jimmunol.0902041.

3.

Blockade of CTLA-4 on both effector and regulatory T cell compartments contributes to the antitumor activity of anti-CTLA-4 antibodies.

Peggs KS, Quezada SA, Chambers CA, Korman AJ, Allison JP.

J Exp Med. 2009 Aug 3;206(8):1717-25. doi: 10.1084/jem.20082492. Epub 2009 Jul 6.

4.

CD4+ regulatory T cells require CTLA-4 for the maintenance of systemic tolerance.

Friedline RH, Brown DS, Nguyen H, Kornfeld H, Lee J, Zhang Y, Appleby M, Der SD, Kang J, Chambers CA.

J Exp Med. 2009 Feb 16;206(2):421-34. doi: 10.1084/jem.20081811. Epub 2009 Feb 2. Erratum in: J Exp Med. 2009 Mar 16;206(3):721.

5.

Cognitive and affective outcomes of more severe compared to less severe carbon monoxide poisoning.

Chambers CA, Hopkins RO, Weaver LK, Key C.

Brain Inj. 2008 May;22(5):387-95. doi: 10.1080/02699050802008075. Erratum in: Brain Inj. 2008 Dec;22(13-14):1038.

PMID:
18415719
6.

Regulation of gammadelta versus alphabeta T lymphocyte differentiation by the transcription factor SOX13.

Melichar HJ, Narayan K, Der SD, Hiraoka Y, Gardiol N, Jeannet G, Held W, Chambers CA, Kang J.

Science. 2007 Jan 12;315(5809):230-3.

7.

Chinese herbal medicine for atopic eczema.

Zhang W, Leonard T, Bath-Hextall F, Chambers CA, Lee C, Humphreys R, Williams HC.

Cochrane Database Syst Rev. 2005 Apr 18;(2):CD002291. Review. Update in: Cochrane Database Syst Rev. 2013;9:CD002291.

PMID:
15846635
8.

Chinese herbal medicine for atopic eczema.

Zhang W, Leonard T, Bath-Hextall F, Chambers CA, Lee C, Humphreys R, Williams HC.

Cochrane Database Syst Rev. 2004 Oct 18;(4):CD002291. Review. Update in: Cochrane Database Syst Rev. 2005;(2):CD002291.

PMID:
15495031
9.

STAT5 is required for thymopoiesis in a development stage-specific manner.

Kang J, DiBenedetto B, Narayan K, Zhao H, Der SD, Chambers CA.

J Immunol. 2004 Aug 15;173(4):2307-14.

10.

The last delivery.

Chambers CA.

Med Econ. 2003 Aug 22;80(16):88. No abstract available.

PMID:
12964548
11.

Topical tacrolimus for cutaneous lupus erythematosus.

Chambers CA.

Br J Dermatol. 2003 Apr;148(4):829; author reply 829. No abstract available.

PMID:
12752154
12.

The lymphoproliferative defect in CTLA-4-deficient mice is ameliorated by an inhibitory NK cell receptor.

Chambers CA, Kang J, Wu Y, Held W, Raulet DH, Allison JP.

Blood. 2002 Jun 15;99(12):4509-16.

PMID:
12036882
13.

The expanding world of co-stimulation: the two-signal model revisited.

Chambers CA.

Trends Immunol. 2001 Apr;22(4):217-23. Review.

PMID:
11274928
14.

CTLA-4-mediated inhibition in regulation of T cell responses: mechanisms and manipulation in tumor immunotherapy.

Chambers CA, Kuhns MS, Egen JG, Allison JP.

Annu Rev Immunol. 2001;19:565-94. Review.

PMID:
11244047
15.

CTLA-4--the costimulatory molecule that doesn't: regulation of T-cell responses by inhibition.

Chambers CA, Allison JP.

Cold Spring Harb Symp Quant Biol. 1999;64:303-12. Review. No abstract available.

PMID:
11232300
16.

Lack of a role for transforming growth factor-beta in cytotoxic T lymphocyte antigen-4-mediated inhibition of T cell activation.

Sullivan TJ, Letterio JJ, van Elsas A, Mamura M, van Amelsfort J, Sharpe S, Metzler B, Chambers CA, Allison JP.

Proc Natl Acad Sci U S A. 2001 Feb 27;98(5):2587-92. Epub 2001 Feb 20.

17.

Cutting edge: two distinct mechanisms lead to impaired T cell homeostasis in Janus kinase 3- and CTLA-4-deficient mice.

Gozalo-Sanmillan S, McNally JM, Lin MY, Chambers CA, Berg LJ.

J Immunol. 2001 Jan 15;166(2):727-30.

18.

Cytotoxic T lymphocyte antigen-4 (CTLA-4) regulates primary and secondary peptide-specific CD4(+) T cell responses.

Chambers CA, Kuhns MS, Allison JP.

Proc Natl Acad Sci U S A. 1999 Jul 20;96(15):8603-8.

19.

CTLA-4-Mediated inhibition of early events of T cell proliferation.

Brunner MC, Chambers CA, Chan FK, Hanke J, Winoto A, Allison JP.

J Immunol. 1999 May 15;162(10):5813-20.

20.

Costimulatory regulation of T cell function.

Chambers CA, Allison JP.

Curr Opin Cell Biol. 1999 Apr;11(2):203-10. Review.

PMID:
10209159
21.

Secondary but not primary T cell responses are enhanced in CTLA-4-deficient CD8+ T cells.

Chambers CA, Sullivan TJ, Truong T, Allison JP.

Eur J Immunol. 1998 Oct;28(10):3137-43.

22.
23.

Thymocyte development is normal in CTLA-4-deficient mice.

Chambers CA, Cado D, Truong T, Allison JP.

Proc Natl Acad Sci U S A. 1997 Aug 19;94(17):9296-301.

24.

Co-stimulation in T cell responses.

Chambers CA, Allison JP.

Curr Opin Immunol. 1997 Jun;9(3):396-404. Review.

PMID:
9203422
25.

The role of tyrosine phosphorylation and PTP-1C in CTLA-4 signal transduction.

Chambers CA, Allison JP.

Eur J Immunol. 1996 Dec;26(12):3224-9.

PMID:
8977326
26.

The role of CTLA-4 in the regulation and initiation of T-cell responses.

Chambers CA, Krummel MF, Boitel B, Hurwitz A, Sullivan TJ, Fournier S, Cassell D, Brunner M, Allison JP.

Immunol Rev. 1996 Oct;153:27-46. Review. No abstract available.

PMID:
9010718
27.

Endogenous interleukin 6 can function as an in vivo growth- stimulatory factor for advanced-stage human melanoma cells.

Lu C, Sheehan C, Rak JW, Chambers CA, Hozumi N, Kerbel RS.

Clin Cancer Res. 1996 Aug;2(8):1417-25.

28.

Effect of Mycoplasma arthritidis superantigen on enzymatically induced arthritis in mice.

Sustackova H, Chambers CA, Hozumi N, Kandel RA, Quinn PA, Cruz TF.

Clin Exp Immunol. 1995 Mar;99(3):352-8.

29.

TKO'ed: lox, stock and barrel.

Chambers CA.

Bioessays. 1994 Dec;16(12):865-8.

PMID:
7840765
30.
31.

Expression of the NK-TR gene is required for NK-like activity in human T cells.

Chambers CA, Gallinger S, Anderson SK, Giardina S, Ortaldo JR, Hozumi N, Roder J.

J Immunol. 1994 Mar 15;152(6):2669-74.

PMID:
8144875
32.

High level functional engraftment of severe combined immunodeficient mice with human peripheral blood lymphocytes following pretreatment with radiation and anti-asialo GM1.

Shpitz B, Chambers CA, Singhal AB, Hozumi N, Fernandes BJ, Roifman CM, Weiner LM, Roder JC, Gallinger S.

J Immunol Methods. 1994 Feb 28;169(1):1-15.

PMID:
7907638
33.
34.

Long term expression of IL-4 in vivo using retroviral-mediated gene transfer.

Chambers CA, Kang J, Hozumi N.

J Immunol. 1992 Nov 1;149(9):2899-905.

PMID:
1401920
35.

Functional heterogeneity of human T cell clones from atopic and non-atopic donors.

Chambers CA, Zimmerman B, Hozumi N.

Clin Exp Immunol. 1992 Apr;88(1):149-56.

36.

Ectopic lymphokine gene expression in human peripheral blood lymphocytes in vivo.

Chambers CA, Kang J, Hozumi N.

Proc Natl Acad Sci U S A. 1992 Feb 1;89(3):1026-30.

37.

A multigene deletion in the immunoglobulin heavy chain region in a highly atopic individual.

Walter MA, Chambers CA, Zimmerman B, Cox DW.

Hum Genet. 1990 Oct;85(6):643-7.

PMID:
2121640
38.

Type VI collagen and glycoprotein MFPI are distinct components of the extracellular matrix.

Ayad S, Chambers CA, Berry L, Shuttleworth CA, Grant ME.

Biochem J. 1986 May 15;236(1):299-302.

39.

Isolation from bovine elastic tissues of collagen type VI and characterization of its form in vivo.

Ayad S, Chambers CA, Shuttleworth CA, Grant ME.

Biochem J. 1985 Sep 1;230(2):465-74.

40.

Collagen heterogeneity and quantification in developing bovine nuchal ligament.

Chambers CA, Shuttleworth CA, Ayad S, Grant ME.

Biochem J. 1984 Jun 1;220(2):385-94.

41.

The effect of digoxin on the response to lithium therapy in mania.

Chambers CA, Smith AH, Naylor GJ.

Psychol Med. 1982 Feb;12(1):57-60.

PMID:
6805000
42.

Immunologic control of the ascites form of murine adenocarcinoma 755. III. Efficacy of serum therapy is controlled by a single genetic locus.

Roloson GJ, Haagensen DE Jr, Chambers CA, Bolognesi DP.

J Immunol. 1981 Jun;126(6):2328-31.

PMID:
7229376
43.

Erythrocyte membrane cation carrier in manic-depressive psychosis.

Naylor GJ, Smith AH, Dick EG, Dick DA, McHarg AM, Chambers CA.

Psychol Med. 1980 Aug;10(3):521-5.

PMID:
6255506
44.

Changes in erythrocyte membrane cation carrier with age in women.

Naylor GJ, Dick EG, Smith AH, Dick DA, McHarg AM, Chambers CA.

Gerontology. 1980;26(6):327-9. No abstract available.

PMID:
7450515
45.

A single genetic locus determines the efficacy of serum therapy against murine adenocarcinoma 755a.

Roloson GJ, Chambers CA, Haagensen DE Jr, Montelaro RC, Bolognesi DP.

Haematol Blood Transfus. 1979;23:469-81. No abstract available.

PMID:
232470
46.

A controlled trial of L-tryptophan in mania.

Chambers CA, Naylor GJ.

Br J Psychiatry. 1978 Jun;132:555-9.

PMID:
350328
47.

The primary sequence of a crustacean satellite DNA containing a family of repeats.

Chambers CA, Schell MP, Skinner DM.

Cell. 1978 Jan;13(1):97-110.

PMID:
620424
48.

Supplemental Content

Loading ...
Support Center